A central role for a region in the middle by Stuttfeld, Edward et al.
TOR SIGNALING
A central role for a region in
the middle
A domain called the ’Conserved region in the middle’ is responsible for
target recognition in the TORC2 complex in fission yeast and the
mTORC2 complex in mammals.
EDWARD STUTTFELD, STEFAN IMSENG AND TIMM MAIER
C
ellular growth is a tightly regulated pro-
cess that depends on the availability of
energy and nutrients. Moreover, in mul-
ticellular species, the proliferation of cells must
be coordinated across tissues and organs. Pro-
tein kinases called target of rapamycin (TOR)
proteins and their mammalian ortholog mTOR
have a central role in growth regulation. These
proteins exert their function in two complexes
called TORC1 and TORC2 (or mTORC1 and
mTORC2 in mammals). These complexes act as
regulatory hubs that integrate input signals con-
cerning the availability of energy and nutrients
or the presence of growth factors. With their
outputs, the mTOR complexes control metabo-
lism and protein biosynthesis, and influence cell
cycle progression, autophagy and cytoskeletal
organization (Laplante and Sabatini, 2012;
Shimobayashi and Hall, 2014).
TOR and mTOR are very large proteins (con-
taining approximately 2300–2600 amino acids)
and are members of the PIKK family of regula-
tory kinases. Both mTOR complexes comprise
mTOR and a protein called mLST8 (Figure 1A).
mTORC1 also contains a protein called Raptor,
whereas mTORC2 further includes the proteins
Rictor and SIN1. In both complexes, the partner
proteins of mTOR determine the target specific-
ity of the mTOR kinase (Cameron et al., 2011;
Nojima et al., 2003). mTORC1 phosphorylates a
diverse set of targets involved in protein biosyn-
thesis, metabolism and transcriptional regula-
tion, while mTORC2’s most prominent targets
are regulatory kinases of the AGC family.
In mTORC1, the Raptor N-terminal conserved
(RNC) domain is known to be involved in the
binding of linear recognition motifs in target
proteins (Dunlop et al., 2009). Recent cryo-elec-
tron microscopy studies have provided a first
glimpse at its function in mTORC1 (Aylett et al.,
2016). The RNC domain is well positioned in the
vicinity of the kinase active site to both recog-
nize target motifs (Beugnet et al., 2003) and to
sterically prevent – in cooperation with parts of
mTOR – bulky non-target proteins accessing the
kinase.
However, less is known about target recogni-
tion in TORC2 and mTORC2. Now, in eLife,
researchers at the Nara Institute of Science and
Technology, Osaka University and the University
of California, Davis – including Hisashi Tatebe
and Shinichi Murayama as joint first authors, and
Tatebe and Kazuhiro Shiozaki as corresponding
authors – report the results of a series of studies
on human SIN1 and its fission yeast ortholog
Sin1, that shed light on the conserved role of
these proteins in target binding (Tatebe et al.,
2017).
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SIN1 and its orthologs are known to contain
four domains (Figure 1B): a variable N-terminal
region (Frias et al., 2006); the ‘Conserved region
in the middle’ (CRIM); an RB domain; and a PH
domain. However, the role of these domains in
mTORC2 target recognition remained unclear,
and structural data were only available for the iso-
lated PH domain (Pan and Matsuura, 2012).
Now Tatebe et al. have clearly shown that the
CRIM domain has a key role in target recognition.
In particular, they demonstrated that in fission
yeast, the CRIM domain in Sin1 is primarily respon-
sible for binding targets from the AGC kinase fam-
ily. In human cell lines, the CRIM domain in SIN1 is
at least involved in recognition of related targets,
implying an evolutionary conserved role for this
domain.
Based on earlier studies (Liu et al., 2015),
SIN1 may even directly interact with the mTOR
kinase domain in mTORC2. Thus, SIN1 might
also be positioned to restrict access of the sub-
strate to the kinase, eventually in cooperation
with Rictor, similar to Raptor in mTORC1.
Tatebe et al. also highlighted the crucial role of
spatial proximity in target recognition by dem-
onstrating that fusion of only the TORC2 target-
binding CRIM domain into TORC1 is sufficient to
let TORC1 phosphorylate a TORC2 substrate.
Tatebe et al. also report an NMR structure for
the CRIM domain in fission yeast that reveals a
ubiquitin-like fold with a prominent acidic loop.
Mutational analysis confirms that target binding
depends on the integrity of the CRIM domain
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Figure 1. Target recognition in mTOR complexes. (A) The protein complexes mTORC1 and mTORC2 regulate
cellular processes and growth via phosphorylation of substrate proteins mediated by the mTOR kinase domain.
mTORC1 signaling (left) is stimulated by growth factors and amino acids, and is inhibited by low cellular energy
levels and hypoxia (a shortage of oxygen). Conserved protein regions involved in target recognition in mTORC1
are located in the Raptor subunit (highlighted in orange). mTORC2 signaling (right) is activated by growth factors
and the substrate binding domain identified by Tatebe et al. – the ’Conserved region in the middle’ (CRIM)
domain – is located in the SIN1 subunit (orange). Prominent downstream targets for each complex are indicated,
including mTORC2 targets from the AGC kinase family: SGK1, AKT and PKCa. (B) The human SIN1 protein (top)
and its fission yeast ortholog Sin1 (bottom) share similar domain organizations. The CRIM domain is involved in
target recognition in both mTORC2 and TORC2. The variable N-terminal domain (which is to the left of the CRIM
domain) has been implicated in SIN1/Sin1’s association with other constituents of mTORC2/TORC2. mLST8:
mammalian lethal with SEC13 protein 8; PH: pleckstrin-homology; PIKK: phosphoinositide-3-kinase-related kinase;
Raptor: regulatory-associated protein of mTOR; RB: (Raf-like) RAS-binding; Rictor: rapamycin-insensitive
companion of mTOR; Sin1/SIN1: stress-activated map kinase-interacting protein 1.
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and strongly suggests that the acidic loop is
involved in binding.
With the functional role and structure of the
CRIM domain now firmly established, research-
ers can start to address the many remaining
questions about TORC2 target recognition. The
NMR structure of the CRIM domain provides an
excellent platform for a detailed analysis of the
recognition of specific motifs in target substrates
by SIN1. However, studies of the overall integra-
tion of SIN1 into mTORC2 will be required to
address the consequences of SIN1-target bind-
ing for subsequent phosphorylation. Finally,
work on target recognition in mTOR complexes
together with recent structural and functional
studies on other PIKK family kinases
(Sibanda et al., 2017) may reveal the presence
(or absence) of common principles in target rec-
ognition across the entire PIKK family.
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